Atlas Trials

Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy

Clinical trial NCT03275337 · COMPLETED

Trial details

NCT number
NCT03275337
Sponsor
Laureate Institute for Brain Research, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Anxiety DisordersSocial Phobia
Start date
2017-08-01
Primary completion
2019-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.